McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, USA.
Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA.
J Thromb Haemost. 2016 Apr;14(4):645-54. doi: 10.1111/jth.13250. Epub 2016 Feb 16.
Platelets are essential for maintaining hemostasis following mechanical injury to the vasculature. Besides this established function, novel roles of platelets are becoming increasingly recognized, which are critical in non-injury settings to maintain vascular barrier integrity. For example, during embryogenesis platelets act to support the proper separation of blood and lymphatic vessels. This role continues beyond birth, where platelets prevent leakage of blood into the lymphatic vessel network. During the course of inflammation, platelets are necessary to prevent local hemorrhage due to neutrophil diapedesis and disruption of endothelial cell-cell junctions. Surprisingly, platelets also work to secure tumor-associated blood vessels, inhibiting excessive vessel permeability and intra-tumor hemorrhaging. Interestingly, many of these novel platelet functions depend on immunoreceptor tyrosine-based activation motif (ITAM) signaling but not on signaling via G protein-coupled receptors, which plays a crucial role in platelet plug formation at sites of mechanical injury. Murine platelets express two ITAM-containing receptors: the Fc receptor γ-chain (FcRγ), which functionally associates with the collagen receptor GPVI, and the C-type lectin-like 2 (CLEC-2) receptor, a hemITAM receptor for the mucin-type glycoprotein podoplanin. Human platelets express an additional ITAM receptor, FcγRIIA. These receptors share common downstream effectors, including Syk, SLP-76 and PLCγ2. Here we will review the recent literature that highlights a critical role for platelet GPVI/FcRγ and CLEC-2 in vascular integrity during development and inflammation in mice and discuss the relevance to human disease.
血小板对于维持血管机械损伤后的止血作用至关重要。除了这一既定功能外,血小板的新作用也越来越受到重视,这些作用在非损伤环境中对于维持血管屏障的完整性至关重要。例如,在胚胎发生过程中,血小板作用于支持血液和淋巴血管的正确分离。这种作用在出生后仍在继续,血小板防止血液漏入淋巴管网络。在炎症过程中,血小板对于防止中性粒细胞穿破和内皮细胞-细胞连接破坏导致的局部出血是必需的。令人惊讶的是,血小板还有助于保护肿瘤相关的血管,抑制血管通透性过度和肿瘤内出血。有趣的是,许多这些新型血小板功能依赖于免疫受体酪氨酸基激活基序(ITAM)信号,而不是 G 蛋白偶联受体的信号,G 蛋白偶联受体在机械损伤部位血小板栓形成中起着至关重要的作用。小鼠血小板表达两种含有 ITAM 的受体:Fc 受体γ链(FcRγ),其与胶原受体 GPVI 功能性相关联,以及 C 型凝集素样 2(CLEC-2)受体,其为粘蛋白型糖蛋白 podoplanin 的 HemITAM 受体。人血小板表达另一种 ITAM 受体,FcγRIIA。这些受体共享共同的下游效应物,包括 Syk、SLP-76 和 PLCγ2。在这里,我们将回顾最近的文献,强调血小板 GPVI/FcRγ 和 CLEC-2 在小鼠发育和炎症过程中血管完整性中的关键作用,并讨论其与人类疾病的相关性。